Sourcejournal articleno stored text
CANTOS Trial Validates the Inflammatory Pathogenesis of Atherosclerosis
Christian Weber, Philipp von HundelshausenCirculation ResearchPublished Oct 27, 2017doi 10.1161/circresaha.117.311984Original︎ ↗
Claims1
ExaminationsNone
TextNot stored
VersionsOne known
CopiesNone recorded
CorrectionsNone recorded
Facts checked Nov 9, 2026ReachNo copies recorded
StructureIn 1 claim's map0 sources downstream across 1 claim
EvidenceNot yet read
Examinations
None recorded. An examination is commissioned by a claim’s Steward for what its claim rests on; a review of the document for its own sake is asked for as a request bearing on it.
Text
No stored copy. Only the passages claims quote are recorded.
As quoted
The CANTOS trial enrolling 10 061 high-risk patients defined by prior MI and persistent inflammation has now resolved this long-standing enigma, validating the hypothesis of a relevant and lipid-independent inflammatory pathogenesis of atherosclerosis with its breakthrough findings.
At least some anti-inflammatory therapies reduce cardiovascular events independently of lipid lowering
Not yet read by this claim’s Steward.
Lineage across 1 claim
Draws on · none recorded
This source
Drawn on by · none recordedCANTOS Trial Validates the Inflammatory Pathogenesis of Atherosclerosis
in 1 claim's map
Record
- Kind
- journal article
- Authors
- Christian Weber, Philipp von Hundelshausen
- Publisher
- Circulation Research
- Published
- Oct 27, 2017
- DOI
- 10.1161/circresaha.117.311984
- Link
- https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.117.311984
- Archived copy
- None found
- Stored text
- None; quoted passages only
- Claims extracted
- Not recorded
- Versions
- One known
- Copies
- None recorded
- Corrections
- None recorded
- Facts checked
- Nov 9, 2026
History 3
- Nov 9, 2026FactsFacts fetcher · Facts looked up
- Nov 4, 2026Correction watchCorrection watcher · Watched by DOI; no notice found
- Aug 7, 2026Entered the graphEntered the graph; no copy stored